193 related articles for article (PubMed ID: 35568077)
1. Single-cell analysis implicates T
McCluskey D; Benzian-Olsson N; Mahil SK; Hassi NK; Wohnhaas CT; ; Burden AD; Griffiths CEM; Ingram JR; Levell NJ; Parslew R; Pink AE; Reynolds NJ; Warren RB; Visvanathan S; Baum P; Barker JN; Smith CH; Capon F
J Allergy Clin Immunol; 2022 Oct; 150(4):882-893. PubMed ID: 35568077
[TBL] [Abstract][Full Text] [Related]
2. A genome-wide meta-analysis of palmoplantar pustulosis implicates T
Hernandez-Cordero A; Thomas L; Smail A; Lim ZQ; Saklatvala JR; Chung R; Curtis CJ; Baum P; Visvanathan S; Burden AD; Cooper HL; Dunnill G; Griffiths CEM; Levell NJ; Parslew R; Reynolds NJ; Wahie S; Warren RB; Wright A; ; Simpson M; Hveem K; Barker JN; Dand N; Løset M; Smith CH; Capon F
J Allergy Clin Immunol; 2024 May; ():. PubMed ID: 38815935
[TBL] [Abstract][Full Text] [Related]
3. Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review.
Lu JD; Lytvyn Y; Mufti A; Zaaroura H; Sachdeva M; Kwan S; Abduelmula A; Kim P; Yeung J
Int J Dermatol; 2023 Jan; 62(1):12-21. PubMed ID: 35128653
[TBL] [Abstract][Full Text] [Related]
4. Increased peripheral Th17 in patients with pustulosis palmaris et plantaris.
Torii K; Furuhashi T; Saito C; Kato H; Nishioka A; Nishida E; Shintani Y; Morita A
Arch Dermatol Res; 2011 Aug; 303(6):441-4. PubMed ID: 21229362
[TBL] [Abstract][Full Text] [Related]
5. What do we know about palmoplantar pustulosis?
Misiak-Galazka M; Wolska H; Rudnicka L
J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):38-44. PubMed ID: 27521275
[TBL] [Abstract][Full Text] [Related]
6. Detection rate of pustules in palmoplantar pustulosis with dermoscopy.
Nakanishi T; Kokubu H; Fujimoto N; Tanaka T
J Dermatol; 2022 Feb; 49(2):299-302. PubMed ID: 34723401
[TBL] [Abstract][Full Text] [Related]
7. Extra-palmoplantar lesions associated with palmoplantar pustulosis.
Yamamoto T
J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1227-32. PubMed ID: 19453807
[TBL] [Abstract][Full Text] [Related]
8. Dietary habits in Japanese patients with palmoplantar pustulosis.
Serizawa N; Okazaki S; Otsuka Y; Koto M; Okabe K; Ito M; Morita T; Hoashi T; Saeki H; Abe N; Mori M; Okubo Y; Yano Y; Mitsui H; Kanda N
J Dermatol; 2021 Mar; 48(3):366-375. PubMed ID: 33404125
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.
Andersen YMF; Augustin M; Petersen J; Hagenström K; Mallbris L; Burge R; Egeberg A
Br J Dermatol; 2019 Nov; 181(5):976-982. PubMed ID: 30815849
[TBL] [Abstract][Full Text] [Related]
10. The microbiome of the "sterile" pustules in palmoplantar pustulosis.
Masuda-Kuroki K; Murakami M; Tokunaga N; Kishibe M; Mori H; Utsunomiya R; Tsuda T; Shiraishi K; Tohyama M; Sayama K
Exp Dermatol; 2018 Dec; 27(12):1372-1377. PubMed ID: 30281856
[TBL] [Abstract][Full Text] [Related]
11. A multicentre open-label study of apremilast in palmoplantar pustulosis (APLANTUS).
Wilsmann-Theis D; Kromer C; Gerdes S; Linker C; Magnolo N; Sabat R; Reich K; Mössner R
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2045-2050. PubMed ID: 34077577
[TBL] [Abstract][Full Text] [Related]
12. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.
Moy AP; Murali M; Kroshinsky D; Duncan LM; Nazarian RM
JAMA Dermatol; 2015 Jul; 151(7):753-60. PubMed ID: 25760640
[TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL)-8 and IL-36γ but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis.
Xiaoling Y; Chao W; Wenming W; Feng L; Hongzhong J
Clin Exp Dermatol; 2019 Jan; 44(1):52-57. PubMed ID: 29896852
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-19 Levels Are Increased in Palmoplantar Pustulosis and Reduced following Apremilast Treatment.
Wolk K; Wilsmann-Theis D; Witte K; Brembach TC; Kromer C; Gerdes S; Ghoreschi K; Reich K; Mössner R; Sabat R
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674793
[TBL] [Abstract][Full Text] [Related]
15. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
[TBL] [Abstract][Full Text] [Related]
16. Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism.
Murakami M; Terui T
J Dermatol Sci; 2020 Apr; 98(1):13-19. PubMed ID: 32201085
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic role of palatine tonsils in palmoplantar pustulosis: A review.
Harabuchi Y; Takahara M
J Dermatol; 2019 Nov; 46(11):931-939. PubMed ID: 31556151
[TBL] [Abstract][Full Text] [Related]
18. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
Menter A; Van Voorhees AS; Hsu S
Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy for palmoplantar pustulosis: A case report.
Huang J; Wu M; Wang H
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103829. PubMed ID: 37806607
[TBL] [Abstract][Full Text] [Related]
20. Similarity and difference between palmoplantar pustulosis and pustular psoriasis.
Yamamoto T
J Dermatol; 2021 Jun; 48(6):750-760. PubMed ID: 33650702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
